Reference91 articles.
1. First-in-class, first-in-human phase I study of selinexor, a selective inhibitor of nuclear export, in patients with advanced solid tumors;Abdul Razak A.R.;Journal of Clinical Oncology,2016
2. Association of XPO1 overexpression with NF-κB and Ki67 in colorectal cancer;Aladhraei M.;Asian Pacific Journal of Cancer Prevention,2019
3. Phase I study of selinexor, a selective inhibitor of nuclear export, in combination with fludarabine and cytarabine, in pediatric relapsed or refractory acute leukemia;Alexander T.B.;Journal of Clinical Oncology,2016
4. XPO1-dependent nuclear export as a target for cancer therapy;Azizian N.G.;Journal of Hematology & Oncology,2020
5. Selective inhibitors of nuclear export block pancreatic cancer cell proliferation and reduce tumor growth in mice;Azmi A.S.;Gastroenterology,2013
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Signal Transduction Inhibitors;Therapeutic Strategies in Veterinary Oncology;2023-08-23
2. Antimetastatic Therapy;Therapeutic Strategies in Veterinary Oncology;2023-08-23
3. Metronomic Chemotherapy;Therapeutic Strategies in Veterinary Oncology;2023-08-23